ACT

NOVEMBER 28/2017


Advertisment

news roundup

OmniComm Systems to Acquire Algorithm

OmniComm Systems, Inc. and Algorithm, Inc. have signed a letter of intent, under which OmniComm will acquire assets and assume liabilities of Algorics to build upon RBM and data analytics.


advertisment

ERT Video Series
Check out the ERT video series, filmed on the show floor at DIA 2017, for interviews on Innovating Clinical Trial Management, eCOA in Clinical Research: Trends and Advances, and Optimizing Clinical Trial Imaging through Advanced Technology.
Click here to watch all 10 short videos

advertisment

Advertisment

EMA to Relocate to Amsterdam

The long waited news of where the EMA will be relocated to due to the United Kingdom's decision to withdraw from the EU has finally been revealed today. The European Medicines Agency will relocate to Amsterdam in the Netherlands just in time for the move in March of 2019.


advertisment

Tomorrow's Clinical Trial, Powered by Modern EDC
See how to cut study build time in half, eliminate migrations, and remove the need for source data verification (SDV).
See a preview and watch the full webinar here.

In this edition

EMA to Relocate to Amsterdam
Community Clinics as Trial Sites
Generating Real-World Data Through Pragmatic Trials
RBM—An Update of Experiences Among European CRAs

Subscribe

Subscribe

Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »


Quanticate Launches Monitoring Services

Quanticate has launched its statistical monitoring service as an extension of its consultancy offering in response to recent amendments to the ICH GCP E6(R2) guidelines which focus on incorporating RBM into trial design.


advertisment

Insight to Drive Better Partnerships
SCORR Marketing, in partnership with Applied Clinical Trials, surveyed life science professionals to gain information about the critical relationship between sponsors and service providers. Read more insights in the CRO Industry Trends report.
Get your copy today


IMAEH Hospital Joins Clinerion's PRS Network of Hospitals

IMAEH, a hospital in Turkey, joins Clinerion's PRS network of hospitals. With this merge, IMAEH will add more than 600 beds including an intensive care unit with 174 beds in 2018. Also, IMAEH will be able to identify and recruit patients in an emergency setting as well as add more than 2 million medical records and 260,000 patient lives to the PRS network.

advertisment

Engaging Rare Disease Patients & Accelerating Clinical Development
In a series of white papers, PRA experts discuss the barriers drug developers face when positioning a new trial in the rare disease space and how to minimize these while engaging with the right patients.
Download the White Papers


Events

Partnerships in Clinical Trials Europe
BioPharma Forum on Cannabis-Based Therapies
Clinical Trial Legal and Contracting Forum
eCOA/ePRO 2017
Search Upcoming Events

advertisment

The Search for an HIV Vaccine: The Past, The Present and The Promise
Live Webcast: Thursday, December 14 at 11:00am EST
Register now


Articles

Community Clinics as Trial Sites

Turning community clinics into research sites requires provision of personnel, processes, technology, and infrastructure to conduct clinical research.


advertisment

Beyond #Buzzwords: How to deploy wearables and remote devices to transform your clinical trial execution
Live Webinar: Tuesday, December 5 at 11:00 am EST
Register now


Four Pillars to Achieve Patient Centricity

ZS Associates specify the four pillars of patient centricity that can help the demands and complexities of clinical trials.

Blog Posts

“There's a Divinity That Shapes Our Ends…”

The decision of where to move the EMA was determined by a coin toss.


advertisment

Navigating the Regulatory Complexities of Orphan Drugs: Know the unwritten rules of designations and what's next
On Demand
Learn more


Generating Real-World Data Through Pragmatic Trials

In this three-part blog series, we look at how electronic platforms can support and enhance data capture in several types of RWD programs: observational studies, pragmatic trials, and commercial programs.


RBM

RBM—An Update of Experiences Among European CRAs

An RBM survey conducted in 2014 was repeated in 2016 in order to find out, how knowledge and practical experience with RBM have changed over that time period.

 

The Risk Based Monitoring Plan

Sponsors and CROs are looking into implementation of a Risk Based Monitoring approach to their clinical trials to achieve the objectives related to enhanced data quality, better monitoring of patient safety, and creating efficiencies in overall operations.


Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription

Get the full picture


Ask the editor

Lisa Henderson
Editor in Chief
Lisa.Henderson@ubm.com

Advertise

Todd Baker
Group Publisher
todd.baker@ubm.com